203 related articles for article (PubMed ID: 20096088)
1. Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of CYP46A1 gene transcription.
Nunes MJ; Milagre I; Schnekenburger M; Gama MJ; Diederich M; Rodrigues E
J Neurochem; 2010 Apr; 113(2):418-31. PubMed ID: 20096088
[TBL] [Abstract][Full Text] [Related]
2. Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination.
Milagre I; Nunes MJ; Moutinho M; Rivera I; Fuso A; Scarpa S; Gama MJ; Rodrigues E
J Alzheimers Dis; 2010; 22(4):1209-21. PubMed ID: 20930312
[TBL] [Abstract][Full Text] [Related]
3. Neuronal differentiation alters the ratio of Sp transcription factors recruited to the CYP46A1 promoter.
Milagre I; Nunes MJ; Castro-Caldas M; Moutinho M; Gama MJ; Rodrigues E
J Neurochem; 2012 Jan; 120(2):220-9. PubMed ID: 22060190
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the human CYP46A1 brain-specific expression by Sp transcription factors.
Milagre I; Nunes MJ; Gama MJ; Silva RF; Pascussi JM; Lechner MC; Rodrigues E
J Neurochem; 2008 Jul; 106(2):835-49. PubMed ID: 18445135
[TBL] [Abstract][Full Text] [Related]
5. Okadaic acid inhibits the trichostatin A-mediated increase of human CYP46A1 neuronal expression in a ERK1/2-Sp3-dependent pathway.
Nunes MJ; Moutinho M; Milagre I; Gama MJ; Rodrigues E
J Lipid Res; 2012 Sep; 53(9):1910-9. PubMed ID: 22693257
[TBL] [Abstract][Full Text] [Related]
6. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
Zhang Y; Dufau ML
J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
[TBL] [Abstract][Full Text] [Related]
7. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.
Choi HS; Lee JH; Park JG; Lee YI
Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149
[TBL] [Abstract][Full Text] [Related]
8. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
Kim SN; Kim NH; Lee W; Seo DW; Kim YK
Mol Cancer Res; 2009 May; 7(5):735-44. PubMed ID: 19435809
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of cholesterol 24-hydroxylase by histone deacetylase inhibitors.
Shafaati M; O'Driscoll R; Björkhem I; Meaney S
Biochem Biophys Res Commun; 2009 Jan; 378(4):689-94. PubMed ID: 19059217
[TBL] [Abstract][Full Text] [Related]
11. Effects of trichostatin A on neuronal mu-opioid receptor gene expression.
Lin YC; Flock KE; Cook RJ; Hunkele AJ; Loh HH; Ko JL
Brain Res; 2008 Dec; 1246():1-10. PubMed ID: 18950606
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression.
Kwon HS; Huang B; Ho Jeoung N; Wu P; Steussy CN; Harris RA
Biochim Biophys Acta; 2006; 1759(3-4):141-51. PubMed ID: 16757381
[TBL] [Abstract][Full Text] [Related]
13. MMP28 gene expression is regulated by Sp1 transcription factor acetylation.
Swingler TE; Kevorkian L; Culley KL; Illman SA; Young DA; Parker AE; Lohi J; Clark IM
Biochem J; 2010 Apr; 427(3):391-400. PubMed ID: 20144149
[TBL] [Abstract][Full Text] [Related]
14. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
Zhao S; Venkatasubbarao K; Li S; Freeman JW
Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
[TBL] [Abstract][Full Text] [Related]
15. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
[TBL] [Abstract][Full Text] [Related]
18. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
[TBL] [Abstract][Full Text] [Related]
19. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
Sekhavat A; Sun JM; Davie JR
Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
[TBL] [Abstract][Full Text] [Related]
20. Sp1 family of transcription factors regulates the human alpha2 (XI) collagen gene (COL11A2) in Saos-2 osteoblastic cells.
Goto T; Matsui Y; Fernandes RJ; Hanson DA; Kubo T; Yukata K; Michigami T; Komori T; Fujita T; Yang L; Eyre DR; Yasui N
J Bone Miner Res; 2006 May; 21(5):661-73. PubMed ID: 16734381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
